Table 2.
Risk factor | Men
|
Women
|
||
---|---|---|---|---|
r | P value | r | P value | |
Body mass index | −0.285 | <0.001 | −0.416 | <0.001 |
Waist to hip ratio | −0.235 | <0.001 | −0.348 | <0.001 |
Systolic blood pressure | −0.030 | 0.443 | −0.060 | 0.104 |
Total cholesterola | −0.065 | 0.107 | −0.022 | 0.559 |
LDL-cholesterola | −0.072 | 0.075 | −0.069 | 0.075 |
HDL-cholesterola | 0.356 | <0.001 | 0.382 | <0.001 |
Triglyceridesa | −0.363 | <0.001 | −0.326 | <0.001 |
HOMA-IRb | −0.359 | <0.001 | −0.465 | <0.001 |
Alcohol consumption | 0.131 | 0.001 | 0.145 | <0.001 |
Creatinine | −0.115 | 0.003 | −0.039 | 0.294 |
Cystatin C | −0.027 | 0.489 | −0.080 | 0.029 |
C-reactive protein | −0.144 | <0.001 | −0.266 | <0.001 |
Fibrinogen | −0.021 | 0.603 | −0.207 | <0.001 |
Leptin | −0.219 | <0.001 | −0.348 | <0.001 |
Health status | −0.001 | 0.985 | −0.053 | 0.149 |
Individuals receiving lipid-lowering therapy excluded.
Individuals receiving glucose-lowering therapy excluded.